Akin Gump·FDA / LIFE SCIENCES REGULATORY
FDA Launches NAIN Neuroscience Initiative With Alzheimer's Prevention Focus
The FDA's new cross-center Neuroscience Advancement and Innovation Nexus, announced October 22, 2026, opens with an Alzheimer's Prevention Accelerator for brain-disease products.
fda-neurosciencealzheimers-preventionregulatory-pathwaysbiomarkersdigital-healthcdrh
Read the original firm alert → Thursday, October 29, 2026